Literature DB >> 17694399

Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

P V Giannoudis1, N K Kanakaris, T A Einhorn.   

Abstract

The present review evaluates the existing scientific proofs of this supplementary role of the BMPs and summarises its clinical implications. Bone regeneration is a process consisting of bone formation and bone resorption, two different but closely coupling pathways, which in most circumstances proceed simultaneously. Plenty of evidence has also characterised the bone morphogenetic proteins (BMPs) as inducing factors of bone formation. However, there is also evidence that these multifunctioning proteins affect bone resorption and the osteoclast homeostasis utilising various pathways. The present review evaluates the existing scientific evidence of this supplementary role of the BMPs, and summarises its clinical implications.

Mesh:

Substances:

Year:  2007        PMID: 17694399     DOI: 10.1007/s00198-007-0441-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  98 in total

1.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Authors:  Hongwei Cheng; Wei Jiang; Frank M Phillips; Rex C Haydon; Ying Peng; Lan Zhou; Hue H Luu; Naili An; Benjamin Breyer; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Tong-Chuan He
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

Review 2.  Clinical applications of recombinant human BMPs: early experience and future development.

Authors:  Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

3.  Role of 1 alpha,25-dihydroxyvitamin D3 in osteoclast differentiation and function.

Authors:  T Suda; E Jimi; I Nakamura; N Takahashi
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 4.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

5.  Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption.

Authors:  S Takahashi; S V Reddy; J M Chirgwin; R Devlin; C Haipek; J Anderson; G D Roodman
Journal:  J Biol Chem       Date:  1994-11-18       Impact factor: 5.157

Review 6.  Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Authors:  Ashley R Poynton; Joseph M Lane
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

7.  Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression.

Authors:  N S Cunningham; V Paralkar; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.

Authors:  E Otsuka; M Notoya; H Hagiwara
Journal:  Calcif Tissue Int       Date:  2003-07       Impact factor: 4.333

9.  Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines.

Authors:  L C Hofbauer; C R Dunstan; T C Spelsberg; B L Riggs; S Khosla
Journal:  Biochem Biophys Res Commun       Date:  1998-09-29       Impact factor: 3.575

10.  Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption.

Authors:  T A Hentunen; P T Lakkakorpi; J Tuukkanen; P P Lehenkari; T K Sampath; H K Väänänen
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

View more
  22 in total

1.  Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.

Authors:  Sofia Bougioukli; Ashish Jain; Osamu Sugiyama; Brian A Tinsley; Amy H Tang; Matthew H Tan; Douglas J Adams; Paul J Kostenuik; Jay R Lieberman
Journal:  Bone       Date:  2015-12-23       Impact factor: 4.398

2.  Adverse effects of posterior lumbar interbody fusion using rhBMP-2.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Domagoj Delimar
Journal:  Eur Spine J       Date:  2009-04-08       Impact factor: 3.134

3.  Are endogenous BMPs necessary for bone healing during distraction osteogenesis?

Authors:  Norine Alam; René St-Arnaud; Dominique Lauzier; Vicki Rosen; Reggie C Hamdy
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

Review 4.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

5.  Bone morphogenetic protein 2 signaling in osteoclasts is negatively regulated by the BMP antagonist, twisted gastrulation.

Authors:  Lan Pham; Kayla Beyer; Eric D Jensen; Julio Sotillo Rodriguez; Julia Davydova; Masato Yamamoto; Anna Petryk; Rajaram Gopalakrishnan; Kim C Mansky
Journal:  J Cell Biochem       Date:  2011-03       Impact factor: 4.429

6.  Smad1/5 and Smad4 expression are important for osteoclast differentiation.

Authors:  Amy Tasca; Melissa Stemig; Aaron Broege; Brandon Huang; Julia Davydova; An Zwijsen; Lieve Umans; Eric D Jensen; Raj Gopalakrishnan; Kim C Mansky
Journal:  J Cell Biochem       Date:  2015-07       Impact factor: 4.429

7.  The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions.

Authors:  Peter V Giannoudis; Nikolaos K Kanakaris; Rozalia Dimitriou; Ian Gill; Vinod Kolimarala; Richard J Montgomery
Journal:  Clin Orthop Relat Res       Date:  2009-04-24       Impact factor: 4.176

8.  Enhancement of difficult nonunion in children with osteogenic protein-1 (OP-1): early experience.

Authors:  Bruno Dohin; Noémi Dahan-Oliel; François Fassier; Reggie Hamdy
Journal:  Clin Orthop Relat Res       Date:  2009-07-09       Impact factor: 4.176

9.  Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism.

Authors:  Kerstin Tiedemann; Iris Boraschi-Diaz; Irina Rajakumar; Jasvir Kaur; Peter Roughley; Dieter P Reinhardt; Svetlana V Komarova
Journal:  J Cell Sci       Date:  2013-09-15       Impact factor: 5.285

10.  Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling.

Authors:  Julio E Sotillo Rodriguez; Kim C Mansky; Eric D Jensen; Ann E Carlson; Toni Schwarz; Lan Pham; BreAnne MacKenzie; Hari Prasad; Michael D Rohrer; Anna Petryk; Rajaram Gopalakrishnan
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.